The pandemic has accelerated growth in scientific research and development, prompting a boost to demand in key R&D clusters. While we don’t expect the current rates of growth to be sustained, we think the outperformance of this sector could persist for the next few years. This bodes well for a handful of markets, with Boston, San Francisco, San Diego and Raleigh-Durham the major beneficiaries.
Subscriber content
Read this in full, free
Start a free trial and use one of your 10 free starter credits to unlock this piece.